miR612 is associated with esophageal squamous cell carcinoma development and metastasis, mediated through TP53

被引:11
|
作者
Zhou, Ping [1 ]
Dong, He [1 ]
He, Shuqian [1 ]
Fang, Lei [1 ]
Jiang, Nan [2 ]
Sun, Qing [1 ]
机构
[1] Shandong Univ, Dept Pathol, Qianfoshan Hosp, 16766 Jingshi Rd, Jinan 250014, Shandong, Peoples R China
[2] Shandong Univ, Sch Med, Dept Pathol, Jinan 250014, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
esophageal squamous cell carcinoma; microRNA-612; TP53; lymph node metastasis; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; MIR-612; SUPPRESSES; GENE-EXPRESSION; DOWN-REGULATION; CANCER; MICRORNA; PROFILES; P53; SURVIVAL;
D O I
10.3892/mmr.2017.6808
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) serve an important role in the regulation of gene expression. In the present study, differential expressions of miRNAs were compared between esophageal squamous cell carcinoma (ESCC) tissues and normal esophageal tissues. In combination with miRNA target prediction databases, a significantly increased expression of miR-612 was discovered in ESCC. The relationship between miR-612 and TP53 gene expression and their roles in ESCC invasion and metastasis was further studied by reverse transcription-quantitative polymerase chain reaction and western blotting in EC109 cells and cancer tissues. The EC109 cell invasion and migration were significantly reduced after miR-612 expression was inhibited. The levels of wild type TP53 protein and mRNA were lower in ESCC tissues compared to the normal esophageal epithelium. In addition, the mRNA and protein expression levels were reported as downregulated further in tumors with metastasis than in tumors without. In conclusion, miR-612 is identified as associated with ESCC development and metastasis, likely through the regulation of TP53 expression, which could be a potential therapeutic target.
引用
收藏
页码:1855 / 1863
页数:9
相关论文
共 50 条
  • [31] Oral squamous cell carcinoma of the tongue dorsum with multiple cancer-associated mutations in the TP53 gene
    Yamasaki, Sachiko
    Tani, Ryouji
    Sakurai, Shigeru
    Toratani, Shigeaki
    Okamoto, Tetsuji
    ORAL ONCOLOGY, 2020, 109
  • [32] High-Risk TP53 Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
    Sandulache, Vlad C.
    Michikawa, Chieko
    Kataria, Pranav
    Gleber-Netto, Frederico O.
    Bell, Diana
    Trivedi, Sanchit
    Rao, Xiayu
    Wang, Jing
    Zhao, Mei
    Jasser, Samar
    Myers, Jeffrey N.
    Pickering, Curtis R.
    CLINICAL CANCER RESEARCH, 2018, 24 (07) : 1727 - 1733
  • [33] TP53 mutation profile of esophageal squamous cell carcinomas of patients from Southeastern Brazil
    Rossini, Ana
    Simao, Tatiana de Almeida
    Marques, Cynthia B.
    Soares-Lima, Sheila C.
    Herbster, Suellen
    Rapozo, Davy Carlos M.
    Andreollo, Nelson A.
    Ferreira, Maria A.
    El-Jaick, Kenya Balbi
    Teixeira, Roberto
    Guimaraes, Denise P.
    Albano, Rodolpho Mattos
    Ribeiro Pinto, Luis Felipe
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2010, 696 (01) : 10 - 15
  • [34] Predicting survival in head and neck squamous cell carcinoma from TP53 mutation
    David L. Masica
    Shuli Li
    Christopher Douville
    Judith Manola
    Robert L. Ferris
    Barbara Burtness
    Arlene A. Forastiere
    Wayne M. Koch
    Christine H. Chung
    Rachel Karchin
    Human Genetics, 2015, 134 : 497 - 507
  • [35] Erratum: Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran
    Alireza Sepehr
    Philippe Tanière
    Ghislaine Martel-Planche
    Abed-Ali Zia'ee
    Ferdous Rastgar-Jazii
    Mansour Yazdanbod
    Gholamreza Etemad-Moghadam
    Farin Kamangar
    Farrokh Saidi
    Pierre Hainaut
    Oncogene, 2002, 21 : 1632 - 1632
  • [36] The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC)
    Corsale, S.
    Rinaldi, G.
    Agnese, V.
    Bazan, V.
    Cammareri, P.
    Calo, V.
    Morello, V.
    Sisto, P. S.
    Cascio, S.
    La Rocca, G.
    Gregorio, V.
    Bruno, L.
    Augello, C.
    Gargano, G.
    Restivo, S.
    Tomasino, R. M.
    Daniele, E.
    Martorana, A.
    Gerbino, A.
    Buscemi, M.
    Castorina, S.
    Pappalardo, A.
    Russo, A.
    Valerio, M. R.
    ANNALS OF ONCOLOGY, 2005, 16 : 167 - 167
  • [37] Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma
    Lindenbergh-van der Plas, Marlon
    Brakenhoff, Ruud H.
    Kuik, Dirk J.
    Buijze, Marijke
    Bloemena, Elisabeth
    Snijders, Peter J. F.
    Leemans, C. Rene
    Braakhuis, Boudewijn J. M.
    CLINICAL CANCER RESEARCH, 2011, 17 (11) : 3733 - 3741
  • [38] Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: A systematic review
    Tornesello, Maria Lina
    Buonaguro, Luigi
    Buonaguro, Franco M.
    GYNECOLOGIC ONCOLOGY, 2013, 128 (03) : 442 - 448
  • [39] Predicting survival in head and neck squamous cell carcinoma from TP53 mutation
    Masica, David L.
    Li, Shuli
    Douville, Christopher
    Manola, Judith
    Ferris, Robert L.
    Burtness, Barbara
    Forastiere, Arlene A.
    Koch, Wayne M.
    Chung, Christine H.
    Karchin, Rachel
    HUMAN GENETICS, 2015, 134 (05) : 497 - 507
  • [40] TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva
    K J Rolfe
    A B MacLean
    J C Crow
    E Benjamin
    W M N Reid
    C W Perrett
    British Journal of Cancer, 2003, 89 : 2249 - 2253